---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004417"
form_type: "8-K"
ticker: "PHIO"
cik: "0001533040"
company_name: "Phio Pharmaceuticals Corp."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:50:10.596809+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Phio shareholders approve reverse stock split (1:2-1:9) and 500K share increase to LTIP

## Summary
- Reverse stock split proposal approved with 1,879,666 For, 313,572 Against; board to set exact ratio and effective date.
- Amendment to 2020 Long Term Incentive Plan approved, increasing shares by 500,000 to total 725,500.
- All five director nominees elected: Bitterman, Bradford, Ferrara, Freeman, Lockshin, each with >559K For votes.
- Ratification of BDO USA as independent auditor for FY 2024 approved with 2,075,307 For votes.

## SEC filing metadata
- accession: 0001683168-24-004417
- form_type: 8-K
- ticker: PHIO
- cik: 0001533040
- company_name: Phio Pharmaceuticals Corp.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533040/000168316824004417/0001683168-24-004417-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533040/000168316824004417/phio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004417
- JSON: https://secwatch.observer/filing/0001683168-24-004417.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004417.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.